Clinical Trial Update: Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial of PI-88 with docetaxel in advanced non-small-cell lung cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PI-88

Snippet

Sponsor: Cellxpert Biotechnology Corp. | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED